Murris-Espin M - Search Results

1

[New therapies for cystic fibrosis targeting the CFTR gene or the CFTR protein].

Hubert D, Bui S, Marguet C, Colomb-Jung V, Murris-Espin M, Corvol H, Munck A. Hubert D, et al. Rev Mal Respir. 2016 Oct;33(8):658-665. doi: 10.1016/j.rmr.2015.11.010. Epub 2016 Jan 21. Rev Mal Respir. 2016. PMID: 26806675 Review. French.

2

[Cystic fibrosis: from the child to the adult].

Murris-Espin M, Didier A. Murris-Espin M, et al. Rev Mal Respir. 2000 Aug;17(3 Pt 2):721-3. Rev Mal Respir. 2000. PMID: 11076381 French. No abstract available.

3

[Coverage rate of influenza vaccine in healthcare workers in the 12 cystic fibrosis centres of the Greater South Region of France in 2005/2006].

Murris-Espin M, Aubert M, Bosdure E, Weil-Olivier C, Dubus JC. Murris-Espin M, et al. Rev Mal Respir. 2008 May;25(5):551-8. doi: 10.1016/s0761-8425(08)71612-7. Rev Mal Respir. 2008. PMID: 18535522 French.

4

[Measurement of pulmonary inflammation in cystic fibrosis].

Fayon M, Chiron R, Abely M; pour le Groupe "Inflammation" de la Société Française de la Mucoviscidose. Fayon M, et al. Rev Mal Respir. 2008 Jun;25(6):705-24. doi: 10.1016/s0761-8425(08)73800-2. Rev Mal Respir. 2008. PMID: 18772828 Review. French.

5

Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis.

Hubert D, Leroy S, Nove-Josserand R, Murris-Espin M, Mely L, Dominique S, Delaisi B, Kho P, Kovarik JM. Hubert D, et al. J Cyst Fibros. 2009 Sep;8(5):332-7. doi: 10.1016/j.jcf.2009.07.001. Epub 2009 Aug 3. J Cyst Fibros. 2009. PMID: 19651542 Free article. Clinical Trial.

6

Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.

Roux AL, Catherinot E, Ripoll F, Soismier N, Macheras E, Ravilly S, Bellis G, Vibet MA, Le Roux E, Lemonnier L, Gutierrez C, Vincent V, Fauroux B, Rottman M, Guillemot D, Gaillard JL; Jean-Louis Herrmann for the OMA Group. Roux AL, et al. J Clin Microbiol. 2009 Dec;47(12):4124-8. doi: 10.1128/JCM.01257-09. Epub 2009 Oct 21. J Clin Microbiol. 2009. PMID: 19846643 Free PMC article.

7

AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis.

Beucher J, Boëlle PY, Busson PF, Muselet-Charlier C, Clement A, Corvol H; French C F Modifier Gene Study Investigators. Beucher J, et al. PLoS One. 2012;7(7):e41913. doi: 10.1371/journal.pone.0041913. Epub 2012 Jul 30. PLoS One. 2012. PMID: 22860029 Free PMC article.

8

Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis.

Boëlle PY, Viviani L, Busson PF, Olesen HV, Ravilly S, Stern M, Assael BM, Barreto C, Drevinek P, Thomas M, Krivec U, Mei-Zahav M, Vibert JF, Clement A, Mehta A, Corvol H; French CF Modifier Gene Study Investigators; European CF Registry Working Group. Boëlle PY, et al. Orphanet J Rare Dis. 2012 Sep 7;7:64. doi: 10.1186/1750-1172-7-64. Orphanet J Rare Dis. 2012. PMID: 22958330 Free PMC article.

9

Erratum à l'article « Nouvelles thérapeutiques de la mucoviscidose ciblant le gène ou la protéine CFTR » [Rev. Mal. Respir. (2016). doi: 10.1016/j.rmr.2015.11.010].

Hubert D, Bui S, Marguet C, Colomb-Jung V, Murris-Espin M, Corvol H, Munck A. Hubert D, et al. Rev Mal Respir. 2016 Jun;33(6):558. doi: 10.1016/j.rmr.2016.02.005. Epub 2016 Apr 23. Rev Mal Respir. 2016. PMID: 27117927 French. No abstract available.

10

Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.

Nové-Josserand R, Grard S, Auzou L, Reix P, Murris-Espin M, Brémont F, Mammar B, Mely L, Hubert D, Durieu I, Burgel PR. Nové-Josserand R, et al. Pediatr Pulmonol. 2017 Feb;52(2):190-197. doi: 10.1002/ppul.23612. Epub 2016 Oct 7. Pediatr Pulmonol. 2017. PMID: 27717223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page